Top Tweets for #R3I
Prof. Peter Libby discusses about what we can learn from the PROMINENT trial. ➡️ https://t.co/z7xNHiLqns
Visit https://t.co/OS9JVVGoW0 for more info.
#R3i #ResidualRisk #MedicalResearch #PROMINENT
Prof. Marja-Riitta Taskinen discusses about non-alcoholic fatty liver disease, dyslipidemia and cardiovascular disease. ➡️ https://t.co/97T190UK75
Visit https://t.co/OS9JVVGoW0 for more info.
#R3i #ResidualRisk #MedicalResearch #NAFLD #Dyslipidemia #CardiovascularDisease #CVD
Prof. Alberto Zambon and Prof. Koutaro Yokote discuss the relevance to residual macrovascular risk when LDL-C is low. ➡️ https://t.co/8JnuNK7Pdt
Visit https://t.co/OS9JVVGoW0 for more info.
#R3i #ResidualRisk #ResidualRiskReduction #MacrovascularRisk #ResidualMacrovascularRisk
Prof. Aruna Pradhan presents insights from the PROMINENT study. ➡️ https://t.co/LshvNfbX0P
Visit https://t.co/OS9JVVGWLy for more info.
#R3i #ResidualRisk #MedicalResearch #PROMINENT
Prof. Raul D. Santos explains why we need new approaches to manage atherogenic dyslipidemia. ➡️ https://t.co/PbGejqisnd
Visit https://t.co/OS9JVVGoW0 for more info.
#R3i #ResidualRisk #MedicalResearch #Dyslipidemia #AtherogenicDyslipidemia
You can view our website in English, Spanish or Japanese by clicking the flag icons in the top right corner.
Become a member to receive our newsletter and get unrestricted access to downloadable slidekits. ➡️ https://t.co/e12A6pOGRU
#R3i #ResidualRisk #ResidualRiskReduction #MedicalResearch
Prof. Alberto Zambon and Prof. Michel Hermans discuss the recent advances in pharmacotherapy of diabetic retinopathy in type 2 diabetes mellitus. ➡️ https://t.co/rW9zyVJNip
Visit https://t.co/OS9JVVGWLy for more info.
#R3i #MedicalResearch #DiabeticRetinopathy #T2DM
Prof. Marja-Riitta Taskinen discusses about non-alcoholic fatty liver disease, dyslipidemia and cardiovascular disease. ➡️ https://t.co/97T190UK75
Visit https://t.co/OS9JVVGoW0 for more info.
#R3i #ResidualRisk #MedicalResearch #NAFLD #Dyslipidemia #CardiovascularDisease #CVD
Prof. Raul Santos (@rauldsf_santos) presents the newest data on targeting cholesterol. ➡️ https://t.co/7wDqqsbYgz
Visit https://t.co/OS9JVVGoW0 for more info.
#R3i #ResidualRisk #ResidualRiskReduction #Cholesterol
Prof. Alberto Zambon and Prof. Michel Hermans discuss the recent advances in pharmacotherapy of diabetic retinopathy in type 2 diabetes mellitus. ➡️ https://t.co/rW9zyVJNip
Visit https://t.co/OS9JVVGWLy for more info.
#R3i #MedicalResearch #DiabeticRetinopathy #T2DM
Introducing Team #R3i Ventures: Rachel Hong and Melvin Loh, Founders of @MeracleHealth , a #Singaporean company leading the charge in respiratory health for #pediatrics, #asthma, #COVID19, and #COPD.
We all live in a world desperate for more effective treatment, prevention, and prediction of #respiratory health. It continues to take a heavy toll on patients despite the development of many new therapies due to incorrect administration techniques of medication and poor compliance.
Enter Meracle. The Whizz spacer revolutionizes respiratory care by enhancing medication delivery efficiency and tracking intake data through a mobile app, optimizing treatment outcomes with gamified compliance features.
Join us on our #JAPAC program at #Planet43 to support their groundbreaking work as Meracle completes their #Seed round to scale up their operations internationally and continue to pave the way for #digitaltherapeutics and a more #valuebasedhealthcare future.
#TeamR3iVentures #Meracle #Singapore #RespiratoryHealth #Pediatrics #Asthma #COVID19 #COPD #Healthcare #MedTech #Innovation #WhizzSpacer #MobileApp #Compliance #TreatmentOutcomes #Gamification #JAPAC #Planet43 #SeedRound #DigitalTherapeutics #ValueBasedHealthcare
Prof. Raed Joundi discusses about advances in diabetes and vascular cognitive impairment. ➡️ https://t.co/HggrdyaSqE
Visit https://t.co/OS9JVVGoW0 for more info.
#R3i #MedicalResearch #Diabetes #VascularCognitiveImpairment
Diabetic retinopathy is already the leading cause of vision loss among working-age adults.
PPARα agonists have emerged as promising therapies for the treatment of #DiabeticRetinopathy as discussed in this webinar.
Sign up here!➡️ https://t.co/4unG4Zqehp
#R3i #Diabetes #Webinar
Prof. Robert Eckel explains the protective effects in diabetic kidney disease, from biomarkers to clinical outcomes.➡️ https://t.co/B0cXBi657E
Visit https://t.co/OS9JVVGoW0 for more info.
#R3i #MedicalResearch #Diabetes #DiabeticKidneyDisease
Prof. Aruna Pradhan discusses about what the PROMINENT results mean for clinical practice. ➡️ https://t.co/UU1FIYwbGT
Visit https://t.co/OS9JVVGoW0 for more info.
#R3i #ResidualRisk #MedicalResearch #PROMINENT
Prof. Robert H. Eckel discusses if clinicians should measure triglycerides or something else. ➡️ https://t.co/y2EoWVYQsF
Visit https://t.co/OS9JVVGWLy for more info.
#R3i #ResidualRisk #ResidualRiskReduction #MedicalResearch #Triglycerides
Lowering low-density lipoprotein cholesterol (LDL-C) with bempedoic acid reduced major adverse cardiovascular events in high-risk patients unable to tolerate statin therapy.
Find out more on our website. ➡️ https://t.co/ElAZ04ktmx
#R3i #MedicalResearch #CardioTwitter
Prof. Raul Santos (@rauldsf_santos) presents the newest data on targeting cholesterol. ➡️ https://t.co/7wDqqsbYgz
Visit https://t.co/OS9JVVGoW0 for more info.
#R3i #ResidualRisk #ResidualRiskReduction #Cholesterol
Results from this preliminary study suggest that pemafibrate may have potential in preventing disease progression in patients with nonalcoholic fatty liver disease (NAFLD) and hypertriglyceridemia.
Learn more here➡️ https://t.co/zd8TSITquN
#R3i #Pemafibrate #NAFLD
Observational and genetic studies as well as evidence from Mendelian randomization trials show that elevated remnant cholesterol is associated with increased risk for #cardiovascular disease, notably ischemic heart disease and stroke.
Learn more ➡️ https://t.co/8HTr7lDUBI
#R3i
Last Seen Hashtags on Sotwe
รับงานสมุทรปราการ
Seen from Thailand
ทหารแก้ผ้า
homelessfuck
Seen from United Kingdom
ผู้หญิงที่น่ารัก
Seen from Thailand
圣水调教
teenagee
Seen from Egypt
nolimit(((())))***++filter:native_video until:2026-6-2
Seen from Egypt
omegletv
Seen from Pakistan
ઉમરથાણા
Seen from Canada
alanbecker
Seen from Netherlands
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.2M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
112.8M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.3M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.4M followers
KATY PERRY
@katyperry
89M followers
Taylor Swift
@taylorswift13
82.9M followers
Lady Gaga
@ladygaga
74.4M followers
Virat Kohli
@imvkohli
71.9M followers
Kim Kardashian
@kimkardashian
70.4M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
64.8M followers
Bill Gates
@billgates
64.6M followers
The Ellen Show
@theellenshow
62.4M followers
Selena Gomez
@selenagomez
62.1M followers
CNN
@cnn
61.8M followers
X
@x
60.8M followers